Influence of growth hormone receptor (GHR) exon 3 and -202A/C IGFBP-3 genetic polymorphisms on clinical and biochemical features and therapeutic outcome of patients with acromegaly (2015)
- Authors:
- Autor USP: JORGE, ALEXANDER AUGUSTO DE LIMA - FM
- Unidade: FM
- DOI: 10.1007/s11102-014-0629-y
- Subjects: POLIMORFISMO; RECEPTORES DA SOMATOTROFINA; GENÓTIPOS; RESULTADO DE TRATAMENTO; AVALIAÇÃO DE PROCESSOS E RESULTADOS; ACROMEGALIA; GENÓTIPOS
- Language: Inglês
- Imprenta:
- Publisher place: Norwell, MA
- Date published: 2015
- Source:
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
JALLAD, Raquel S. et al. Influence of growth hormone receptor (GHR) exon 3 and -202A/C IGFBP-3 genetic polymorphisms on clinical and biochemical features and therapeutic outcome of patients with acromegaly. Pituitary, v. 18, n. 5, p. 666-673, 2015Tradução . . Disponível em: http://link.springer.com/article/10.1007%2Fs11102-014-0629-y. Acesso em: 21 jun. 2025. -
APA
Jallad, R. S., Trarbach, E. B., Duarte, F. H., Jorge, A. A. L., & Bronstein, M. D. (2015). Influence of growth hormone receptor (GHR) exon 3 and -202A/C IGFBP-3 genetic polymorphisms on clinical and biochemical features and therapeutic outcome of patients with acromegaly. Pituitary, 18( 5), 666-673. doi:10.1007/s11102-014-0629-y -
NLM
Jallad RS, Trarbach EB, Duarte FH, Jorge AAL, Bronstein MD. Influence of growth hormone receptor (GHR) exon 3 and -202A/C IGFBP-3 genetic polymorphisms on clinical and biochemical features and therapeutic outcome of patients with acromegaly [Internet]. Pituitary. 2015 ; 18( 5): 666-673.[citado 2025 jun. 21 ] Available from: http://link.springer.com/article/10.1007%2Fs11102-014-0629-y -
Vancouver
Jallad RS, Trarbach EB, Duarte FH, Jorge AAL, Bronstein MD. Influence of growth hormone receptor (GHR) exon 3 and -202A/C IGFBP-3 genetic polymorphisms on clinical and biochemical features and therapeutic outcome of patients with acromegaly [Internet]. Pituitary. 2015 ; 18( 5): 666-673.[citado 2025 jun. 21 ] Available from: http://link.springer.com/article/10.1007%2Fs11102-014-0629-y - Aplicação da genética molecular no manejo dos distúrbios do crescimento
- Deficiência da STAT5B: uma nova síndrome de insensibilidade ao hormônio de crescimento associada a acometimento imunológico
- Growth hormone therapy in children; research and practice: a review
- Deficiências hipotálamo-hipofisárias múltiplas por mutações no gene GLI2
- Clinical Characterization of Patients With Autosomal Dominant Short Stature due to Aggrecan Mutations
- Clinical and genetic characterization and long-term evaluation of individuals with maturity-onset diabetes of the young (MODY): the journey towards appropriate treatment
- A novel STAT5B mutation causing GH insensitivity syndrome associated with hyperprolactinemia and immune dysfunction in two male siblings
- Management of endocrine disease: Diagnostic and therapeutic approach of tall stature
- Whole Exome Sequencing in the Investigation of Growth Disorders, Including Patients with Primary IGF-1 Deficiency
- Long-term response to growth hormone therapy in a patient with short stature caused by a novel heterozygous mutation in NPR2
Informações sobre o DOI: 10.1007/s11102-014-0629-y (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
